Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/15/2025

Management of Diffuse Subarachnoid Hemorrhage

Immediate Diagnostic Workup

  • The American Heart Association recommends that patients with diffuse subarachnoid hemorrhage undergo immediate non-contrast head CT, which has a sensitivity of 98-100% within 12 hours, declining to 93% at 24 hours 1, 3
  • Digital subtraction angiography (DSA) is mandatory for evaluating cerebrovascular anatomy and aneurysm geometry in diffuse SAH, as small aneurysms or vascular lesions may not be detected on CTA due to spatial resolution limitations 1, 3

Acute Stabilization and Monitoring

  • The American College of Cardiology recommends that care be provided in a dedicated neurocritical care unit by a multidisciplinary team, including neurosurgeons, neurointerventionalists, and neurointensivists, to reduce mortality from 39% to 27% 1, 2
  • Rapid assessment of neurological status using validated grading scales, such as the Hunt-Hess or World Federation of Neurological Surgeons scale, is crucial, as initial clinical severity is the strongest predictor of outcome 1, 5
  • Control of blood pressure with titratable agents is necessary to balance rebleeding risk against maintaining cerebral perfusion pressure, with ultraearly rebleeding risk being 15% within the first 24 hours 1, 4, 5

Definitive Aneurysm Treatment

  • Early aneurysm obliteration should be performed urgently to reduce rebleeding risk, with the risk of rebleeding increasing with time: 5.7% at 0-3 days, 9.4% at 4-6 days, and 21.5% at 15-32 days if untreated 1, 4
  • For aneurysms amenable to both surgical clipping and endovascular coiling, endovascular coiling is the preferred approach based on superior functional outcomes in randomized trials 1, 6

Medical Management

  • Oral nimodipine 60 mg every 4 hours for 21 consecutive days, starting within 96 hours of hemorrhage onset, improves neurological outcomes, though it does not prevent vasospasm itself 2, 4, 6

Prevention and Management of Delayed Cerebral Ischemia (DCI)

  • Maintenance of euvolemia and normal circulating blood volume through goal-directed fluid management is recommended, with avoidance of prophylactic hypervolemia as it does not improve outcomes and may be harmful 2, 6
  • For symptomatic DCI, induction of hypertension as first-line therapy is recommended, unless baseline blood pressure is already elevated or cardiac status precludes it 2, 4, 6

Management of Acute Complications

  • Urgent placement of external ventricular drainage is necessary for acute symptomatic hydrocephalus, which is a common and life-threatening complication 2, 4, 6
  • Recent evidence suggests that when preoperative ventriculostomy is followed by early aneurysm treatment, rebleeding risk is not increased 5

Additional Considerations

  • Short-term tranexamic acid or aminocaproic acid is reasonable to reduce early rebleeding risk in patients with significant delay to aneurysm obliteration and no medical contraindications 2
  • Venous thromboembolism prophylaxis should be initiated once the aneurysm is secured 6
  • Avoidance of phenytoin for seizure prophylaxis is recommended, as it is associated with excess morbidity and mortality 6

Follow-up Imaging

  • Immediate post-treatment cerebrovascular imaging is necessary to identify aneurysm remnants or recurrence, with delayed follow-up vascular imaging recommended to detect any clinically significant remnants 2, 4, 6